Evidence Suggests the COVID Shots Are Responsible for Soaring RSV Cases Throughout the U.S. & Canada

"Across the board, you see more cases of RSV in the vaccinated group than in the placebo group."

261
105

Hospital beds are filling up as RSV cases surge across the United States and Canada. It’s getting so bad that one San Diego school saw nearly 40% of students take absence after a hard-hitting respiratory wave.

Traditional media would like to gaslight you and blame COVID-19 for this sudden rise. But the folks at The Highwire did some digging and found damning evidence against the shots. And they did so using FDA documents involving Pfizer and Moderna’s own clinical trials.

Moderna

Two to Five-Year-Olds

Within 28 days after vaccination, some respiratory tract-related infections were reported with greater frequency in the mRNA-1273 group than in the placebo group. Events of pneumonia were reported by 0.3% and 0% 0f mRNA-1273 and placebo recipients, respectively. Respiratory syncytial virus (RSV) infection was reported by 0.4% and <0.1% of mRNA-1273 and placebo recipients, respectively.

“So FOUR TIMES THE AMOUNT OF RSV in the vaccinated group compared to the unvaccinated group that hadn't received it,” noted Del Bigtree.

Moving on to Six to Eleven-Year-Olds

Within 28 days after vaccination, some respiratory tract infection-related PTs were reported more frequently in the vaccine group compared to the placebo group, such as Respiratory syncytial virus infection (0.3% vs 0%) and Upper respiratory tract infection (3.9% vs 2.5%).

“So you're giving a shot to kids that's INCREASING their upper respiratory tract infections with RSV quite a bit, actually,” observed Jeffrey Jaxen.

Pfizer

Six-Month to Four-Year-Olds (Third Dose)

SAEs (serious adverse events) reported in the BNT162b2 group included RSV bronchiolitis (5 participants).

SAEs reported in the placebo group included bronchiolitis or RSV bronchiolitis (3 participants).

So again, across the board, you see more cases of RSV in the vaccinated group than in the placebo group. These findings led the lawyers at ICAN (Informed Consent Action Network) to send this letter to CDC Director Rochelle Walensky.

Given the CDC's robust and ongoing data collection among those tested for and positive for RSV, please let us know the percent of children who have tested positive for RSV who had received a Covid-19 vaccine prior to their RSV diagnosis.

Now, if the CDC were a competent organization, they would be doing the science on this information. But, as Del Bigtree puts it:

They like the head-in-the-sand method, which is “Let’s don’t ask any of the obvious questions — like why do we suddenly have outbreaks of RSV beyond anything we’ve ever seen before? Could it possibly be that injection that we know lowers the immune system and showed within 28 days an increase in RSV?”…

Del then ends the segment on this note:

Is it possible that the 40 or 50% that are leaving the school happened to be going through that because the vaccination? Look — we don’t know. But what’s curious is why no one media and no one at the CDC is asking the most obvious question.

I think we all know the answer to that…


Thanks for reading. If you like my work and want to help keep it going, consider becoming a free or paid subscriber — or share this post.

Share

Get 7 day free trial